BioAgilytix has recently been awarded the 2020 Fast 50 Award by Triangle Business Journal as one of the fastest-growing private companies within our region.
PRNewswire covers the news of welcoming Kennon Broadhurst to the BioAgilytix team, bringing with him over 26 years of experience in sales, marketing and product commercialization experience.
In this article, North Carolina Biotechnology Center covers the topic of BioAgilytix partnering with BRIO Systems to launch a platform that provides U.S. employers with effective comprehensive COVID-19 testing programs.
WRAL TechWire explains how BioAgilytix Labs has partnered with Boston’s BRIO Systems to launch its COVIDence™ platform to provide U.S. employers comprehensive COVID-19 testing programs.
In this news article, Bioanalysis Zone covers the launch of BioAgilytix’s COVIDence™, a complete COVID-19 workforce testing service for employers with support from BRIO Systems.
This article by Verdict Medical Devices covers the launch of BioAgilytix’s COVIDence™, a complete COVID-19 workforce testing service designed to help US employers reduce the exposure and spread of COVID-19.
The Business Wire covers the launch of BioAgilytix’s new end-to-end COVIDence™ program, a comprehensive COVID-19 employee testing service with support from BRIO Systems.
BioAgilytix supplies its assay expertise to describe the appropriate analytical assays needed to determine and ensure that biosimilar critical quality parameters are on track.
In this article, Bioanalysis Zone explores the launch of BioAgilytix’s new range of customizable COVID-19 testing packages with commentary from leadership team members.
This article by Applied Clinical Trials explores BioAgilytix’s new customizable COVID-19 testing packages that include services to address sponsor needs stemming from the coronavirus pandemic.
WRAL TechWire lists BioAgilytix’s new COVID-19 testing packages as noteworthy technology news affecting the North Carolina ecosystem.
This article by Verdict Medical Devices explores BioAgilytix’s new customizable COVID-19 testing packages, which include return-to-work screening for employers and assays for clinical sponsors.
The Business Wire covers the launch of BioAgilytix’s customizable COVID-19 testing packages, which include services to address a breadth of sponsor and employer needs stemming from the coronavirus pandemic.
3rd Watch News lists BioAgilytix as a top, key player in its “COVID-19 Impact on Global Cell-based Assays Market Size, Status and Forecast 2020-2026.”
The Derrick explores BioAgilytix’s new customizable COVID-19 testing packages with services to address a breadth of sponsor and employer needs stemming from the coronavirus pandemic.
PRNewswire covers BioAgilytix’s listing on The “Bioanalytical Testing Services Market by Type, Application, End User – Global Forecasts to 2025 ” report that was added to ResearchAndMarkets.com’s offering.
Services
Platforms